A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukaemia

Opat, Stephen (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA HREC Reference Number: HREC/19/CALHN/384
NMA SSA Reference Number: SSA/57485/MonH-2019-186227(v1)
Monash Health Ref: RES-19-0000-662X

Status	Finished
Effective start/end date	10/10/19 → 9/10/24

Keywords

clinical trial
phase 3 study
treatment efficacy
leukaemia